To access this element change to forms mode OFF
Grant Award View - GA65921
Targeting DNA-PK in acute myeloid leukaemia
GA ID:
GA65921
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$741,610.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Targeting DNA-PK in acute myeloid leukaemia
Purpose:
This study will test a potential new strategy for treating the devastating blood cancer, acute myeloid leukaemia (AML). In exciting preliminary studies we have identified a molecular pathway that is over-activated in poor response AML patients. We have shown that inhibiting this pathway with new pharmaceuticals kills AML cells, and that these drugs work in synergy with standard AML therapies. We will now test the efficacy of this new treatment strategy in pre-clinical studies.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1188400
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA